$0.7113
-0.02-2.83%
At close: -
$0.7002
-0.01-1.56%
After Hours: Mar 21, 6:43 PM EDT
Comments
Loading...
Seres Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:MCRB | Benzinga
Seres Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.190
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Seres Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics | -$0.27 | -$0.19 | — | — | $0.00 | — | — | — | 05/07/2025 | Get Alert |
| MCRB | Seres Therapeutics | -$0.32 | -$0.20 | -$0.08 | 60.00% | $64.00K | — | $0.00 | — | 03/13/2025 | Get Alert |
| MCRB | Seres Therapeutics | -$0.37 | -$0.24 | -$0.33 | -37.50% | $310.00K | — | $0.00 | — | 11/13/2024 | Get Alert |
| MCRB | Seres Therapeutics | $0.36 | -$0.27 | -$0.22 | 18.52% | $126.47M | — | $0.00 | — | 08/13/2024 | Get Alert |
| MCRB | Seres Therapeutics | -$0.57 | -$0.34 | -$0.27 | 20.59% | -$522.00K | $250.00K | $0.00 | -100.00% | 05/08/2024 | Get Alert |
| MCRB | Seres Therapeutics | -$0.54 | -$0.50 | -$0.32 | 36.00% | $975.00K | — | $64.00K | — | 03/05/2024 | Get Alert |
| MCRB | Seres Therapeutics | -$0.49 | -$0.50 | -$0.37 | 26.00% | $3.44M | $1.87M | $310.00K | -83.42% | 11/02/2023 | Get Alert |
| MCRB | Seres Therapeutics | -$0.70 | $0.55 | $0.36 | -34.55% | $1.22M | $125.50M | $126.47M | 0.78% | 08/08/2023 | Get Alert |
| MCRB | Seres Therapeutics | -$0.61 | -$0.55 | -$0.57 | -3.64% | $1.49M | $1.38M | -$522.00K | -137.83% | 05/09/2023 | Get Alert |
| MCRB | Seres Therapeutics | -$0.55 | -$0.46 | -$0.54 | -17.39% | $7.22M | — | $975.00K | — | 03/07/2023 | Get Alert |
| MCRB | Seres Therapeutics | $0.72 | -$0.47 | -$0.49 | -4.26% | $126.72M | $7.00M | $3.44M | -50.80% | 11/02/2022 | Get Alert |
| MCRB | Seres Therapeutics | -$0.53 | -$0.60 | -$0.70 | -16.67% | $5.26M | — | $1.22M | — | 08/03/2022 | Get Alert |
| MCRB | Seres Therapeutics | -$0.39 | -$0.52 | -$0.61 | -17.31% | $5.72M | — | $1.49M | — | 05/04/2022 | Get Alert |
| MCRB | Seres Therapeutics | -$0.19 | -$0.44 | -$0.55 | -25.00% | $17.56M | $12.25M | $7.22M | -41.05% | 03/01/2022 | Get Alert |
| MCRB | Seres Therapeutics | -$0.36 | -$0.46 | $0.72 | 256.52% | $1.42M | $7.32M | $126.72M | 1631.22% | 11/10/2021 | Get Alert |
| MCRB | Seres Therapeutics | -$0.28 | -$0.37 | -$0.53 | -43.24% | $6.04M | $5.34M | $5.26M | -1.44% | 08/03/2021 | Get Alert |
| MCRB | Seres Therapeutics | -$0.28 | -$0.31 | -$0.39 | -25.81% | $8.19M | $6.45M | $5.72M | -11.35% | 05/04/2021 | Get Alert |
| MCRB | Seres Therapeutics | -$0.25 | -$0.28 | -$0.19 | 32.14% | $7.62M | $6.93M | $17.56M | 153.45% | 03/02/2021 | Get Alert |
| MCRB | Seres Therapeutics | -$0.23 | -$0.25 | -$0.36 | -44.00% | $7.03M | — | $1.42M | — | 11/09/2020 | Get Alert |
| MCRB | Seres Therapeutics | -$0.24 | -$0.26 | -$0.28 | -7.69% | $12.53M | $9.54M | $6.04M | -36.64% | 07/28/2020 | Get Alert |
| MCRB | Seres Therapeutics | -$0.59 | -$0.28 | -$0.28 | 0.00% | $7.32M | $8.53M | $8.19M | -4.00% | 05/07/2020 | Get Alert |
Seres Therapeutics (MCRB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-13 | $-0.08 | $-0.20 | 60.0 % |
| Q3 | 2024-11-13 | $-0.33 | $-0.24 | -37.5 % |
| Q2 | 2024-08-13 | $-0.22 | $-0.27 | 18.5 % |
| Q1 | 2024-05-08 | $-0.27 | $-0.34 | 20.6 % |
Seres Therapeutics (MCRB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-05-08 | $0 | $250.00K | -100.0 % |
| Q3 | 2023-11-02 | $310.00K | $1.87M | -83.4 % |
| Q2 | 2023-08-08 | $126.47M | $125.50M | 0.78 % |
| Q1 | 2023-05-09 | $-522.00K | $1.38M | -137.8 % |
FAQ
When is Seres Therapeutics (NASDAQ:MCRB) reporting earnings?
Seres Therapeutics (MCRB) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Seres Therapeutics (NASDAQ:MCRB)?
The Actual EPS was $-0.08, which beat the estimate of $-0.20.
What were Seres Therapeutics’s (NASDAQ:MCRB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.